Inventor · disambiguated record
Paul R. Fatheree
Also filed as: FATHEREE PAUL · FATHEREE PAUL R · FATHEREE PAUL ROSS
143 granted patents·19 pending applications·1,658 citations·filing 1993–2023
99Inventor score
Files withTHERAVANCE INC65THERAVANCE BIOPHARMA R&D IP LLC27CHOI SEOK-KI12FATHEREE PAUL R12ALLEGRETTI PAUL9
Top patents by PatentIndex Score
162 records- 0198US10526330B2JAK kinase inhibitor compounds for treatment of respiratory diseaseTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2018·Granted Jan 7, 2020·15 cites·13 claims
- 0298US10208040B2Fused imidazo-piperidine JAK inhibitorsTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2018·Granted Feb 19, 2019·24 cites·31 claims
- 0398US10196393B2JAK inhibitors containing a 4-membered heterocyclic amideTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2018·Granted Feb 5, 2019·24 cites·12 claims
- 0498US10100049B2JAK kinase inhibitor compounds for treatment of respiratory diseaseTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2016·Granted Oct 16, 2018·28 cites·17 claims
- 0598US7879896B2Dual-acting imidazole antihypertensive agentsTHERAVANCE INC·Filed 2008·Granted Feb 1, 2011·53 cites·30 claims
- 0698US7777077B2Dual-acting antihypertensive agentsTHERAVANCE INC·Filed 2008·Granted Aug 17, 2010·34 cites·34 claims
- 0798US7655621B2Cross-linked glycopeptide-cephalosporin antibioticsTHERAVANCE INC·Filed 2007·Granted Feb 2, 2010·26 cites·12 claims
- 0898US7649080B2Cross-linked glycopeptide-cephalosporin antibioticsTHERAVANCE INC·Filed 2007·Granted Jan 19, 2010·24 cites·18 claims
- 0998US7601690B2Cross-linked glycopeptide-cephalosporin antibioticsTHERAVANCE INC·Filed 2007·Granted Oct 13, 2009·25 cites·6 claims
- 1098US7553962B2Cross-linked glycopeptide-cephalosporin antibioticsTHERAVANCE INC·Filed 2007·Granted Jun 30, 2009·21 cites·24 claims
- 1197US10550118B2JAK inhibitors containing a 4-membered heterocyclic amideTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2019·Granted Feb 4, 2020·13 cites·10 claims
- 1297US10519153B2Fused imidazo-piperidine JAK inhibitorsTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2018·Granted Dec 31, 2019·16 cites·22 claims
- 1397US10392386B2JAK inhibitors containing a 4-membered heterocyclic amideTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2018·Granted Aug 27, 2019·19 cites·10 claims
- 1497US9725470B2Substituted naphthyridines as JAK kinase inhibitorsTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2016·Granted Aug 8, 2017·27 cites·19 claims
- 1597US8013005B2Dual-acting antihypertensive agentsTHERAVANCE INC·Filed 2008·Granted Sep 6, 2011·42 cites·22 claims
- 1697US7834041B2Dual-acting antihypertensive agentsTHERAVANCE INC·Filed 2008·Granted Nov 16, 2010·29 cites·24 claims
- 1797US7375114B2Quinolinone-carboxamide compounds as 5-HT4 receptor agonistsTHERAVANCE INC·Filed 2005·Granted May 20, 2008·41 cites·17 claims
- 1897US7341993B2Cross-linked glycopeptide—cephalosporin antibioticsTHERAVANCE INC·Filed 2005·Granted Mar 11, 2008·22 cites·2 claims
- 1997US6974797B2Cross-linked glycopeptide-cephalosporin antibioticsTHERAVANCE INC·Filed 2002·Granted Dec 13, 2005·45 cites·25 claims
- 2096US10493077B2Fused imidazo-piperidine JAK inhibitor compoundTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2018·Granted Dec 3, 2019·14 cites·19 claims
- 2196US8372984B2Dual-acting oxazole antihypertensive agentsTHERAVANCE INC·Filed 2010·Granted Feb 12, 2013·16 cites·15 claims
- 2296US7728127B2Cross-linked glycopeptide-cephalosporin antibioticsTHERAVANCE INC·Filed 2007·Granted Jun 1, 2010·20 cites·17 claims
- 2396US7612037B2Cross-linked glycopeptide-cephalosporin antibioticsTHERAVANCE INC·Filed 2007·Granted Nov 3, 2009·18 cites·13 claims
- 2496US7332471B2Cross-linked glycopeptide-cephalosporin antibioticsTHERAVANCE INC·Filed 2006·Granted Feb 19, 2008·21 cites·23 claims
- 2596US7279458B2Cross-linked glycopeptide-cephalosporin antibioticsTHERAVANCE INC·Filed 2006·Granted Oct 9, 2007·50 cites·12 claims
- 2695US10028960B2Pyrimidine compounds as JAK kinase inhibitorsTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2017·Granted Jul 24, 2018·18 cites·13 claims
- 2795US7067481B2Cross-linked glycopeptide-cephalosporin antibioticsTHERAVANCE INC·Filed 2004·Granted Jun 27, 2006·41 cites·35 claims
- 2895US6878686B2Cross-linked glycopeptide-cephalosporin antibioticsTHERAVANCE INC·Filed 2003·Granted Apr 12, 2005·49 cites·27 claims
- 2994US11453668B2JAK inhibitors containing a 4-membered heterocyclic amideTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2021·Granted Sep 27, 2022·2 cites·20 claims
- 3094US10913740B2JAK kinase inhibitor compounds for treatment of respiratory diseaseTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2019·Granted Feb 9, 2021·5 cites·18 claims
- 3194US7989484B2Dual-acting antihypertensive agentsTHERAVANCE INC·Filed 2009·Granted Aug 2, 2011·25 cites·21 claims
- 3294US7956054B2Dual-acting pyrazole antihypertensive agentsTHERAVANCE INC·Filed 2010·Granted Jun 7, 2011·21 cites·16 claims
- 3394US7863309B2Dual-acting antihypertensive agentsTHERAVANCE INC·Filed 2009·Granted Jan 4, 2011·27 cites·27 claims
- 3494US7759363B2Benzimidazole-carboxamide compounds as 5-HT4, receptor agonistsTHERAVANCE INC·Filed 2006·Granted Jul 20, 2010·18 cites·18 claims
- 3594US7713931B2Cross-linked glycopeptide-cephalosporin antibioticsTHERAVANCE INC·Filed 2007·Granted May 11, 2010·7 cites·19 claims
- 3694US7396933B2Quinolinone-carboxamide compoundsTHERAVANCE INC·Filed 2005·Granted Jul 8, 2008·28 cites·13 claims
- 3794US7351704B2Indazole-carboxamide compounds as 5-HT4 receptor agonistsTHERAVANCE INC·Filed 2005·Granted Apr 1, 2008·25 cites·19 claims
- 3894US6756400B2Sodium channel modulatorsTHERAVANCE INC·Filed 2001·Granted Jun 29, 2004·36 cites·14 claims
- 3993US11299492B2JAK kinase inhibitor compounds for treatment of respiratory diseaseTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2021·Granted Apr 12, 2022·2 cites·13 claims
- 4093US11254669B2Fused imidazo-piperidine JAK inhibitorsTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2019·Granted Feb 22, 2022·3 cites·17 claims
- 4193US8212052B2Dual-acting benzoimidazole antihypertensive agentsCHOI SEOK-KI·Filed 2008·Granted Jul 3, 2012·23 cites·23 claims
- 4293US7728006B2Quinolinone-carboxamide compounds as 5-HT4 receptor agonistsTHERAVANCE INC·Filed 2005·Granted Jun 1, 2010·11 cites·18 claims
- 4393US7592355B2Quinolinone-carboxamide compounds as 5-HT, receptor agonistsTHERAVANCE INC·Filed 2007·Granted Sep 22, 2009·13 cites·20 claims
- 4493US7419989B2Indazole-carboxamide compoundsTHERAVANCE INC·Filed 2005·Granted Sep 2, 2008·19 cites·12 claims
- 4593US7399862B25-HT4 receptor agonist compoundsTHERAVANCE INC·Filed 2005·Granted Jul 15, 2008·26 cites·12 claims
- 4693US6995138B2Cross-linked glycopeptide-cephalosporin antibioticsTHERAVANCE INC·Filed 2004·Granted Feb 7, 2006·34 cites·6 claims
- 4793US6646012B2Sodium channel modulatorsTHERAVANCE INC·Filed 2002·Granted Nov 11, 2003·30 cites·16 claims
- 4893US6444786B1Glycopeptide derivatives and pharmaceutical compositions containing the sameADVANCED MEDICINE INC·Filed 2000·Granted Sep 3, 2002·41 cites·32 claims
- 4992US10954237B2JAK inhibitors containing a 4-membered heterocyclic amideTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2019·Granted Mar 23, 2021·2 cites·18 claims
- 5092US8377964B2Benzimidazole-carboxamide compounds as 5-HT4 receptor agonistsTHERAVANCE INC·Filed 2010·Granted Feb 19, 2013·10 cites·17 claims
Showing the top 50 of 162 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →